Analyst Price Targets — VCEL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 18, 2025 2:16 pm | Richard Newitter | Truist Financial | $45.00 | $36.42 | TheFly | Vericel price target lowered to $45 from $50 at Truist |
| October 15, 2025 12:48 pm | — | Truist Financial | $41.00 | $34.50 | TheFly | Vericel price target lowered to $41 from $46 at Truist |
| December 18, 2024 12:32 pm | Richard Newitter | Truist Financial | $67.00 | $56.25 | TheFly | Vericel price target raised to $67 from $61 at Truist |
| August 26, 2024 9:33 am | Ryan Zimmerman | BTIG | $55.00 | $50.05 | StreetInsider | BTIG Reiterates Buy Rating on Vericel Corporation (VCEL) |
| August 2, 2024 6:07 am | Swayampakula Ramakanth | H.C. Wainwright | $60.00 | $47.52 | TheFly | Vericel price target raised to $60 from $55 at H.C. Wainwright |
| July 16, 2024 9:46 am | Richard Newitter | Truist Financial | $57.00 | $52.10 | TheFly | Vericel price target raised to $57 from $56 at Truist |
| July 5, 2024 10:09 am | Ryan Zimmerman | BTIG | $56.00 | $46.68 | StreetInsider | BTIG Reiterates Buy Rating on Vericel Corporation (VCEL) |
| January 25, 2024 6:02 am | Samuel Brodovsky | Truist Financial | $51.00 | $42.60 | StreetInsider | Truist Securities Upgrades Vericel Corporation (VCEL) to Buy |
| January 3, 2023 11:03 am | — | H.C. Wainwright | $37.00 | $25.13 | Benzinga | HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $37 |
| December 20, 2022 8:36 am | — | Truist Financial | $25.00 | $23.20 | Benzinga | Truist Securities Maintains Hold on Vericel, Raises Price Target to $25 |
Latest News for VCEL
Vericel Corporation (VCEL) came out with quarterly earnings of $0.45 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.38 per share a year ago.
Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript
Total Revenue of $276.3 Million, with MACI Revenue Growth of 21% to $239.5 Million Net Income Growth of 59% to $16.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% Record Fourth Quarter Gross Margin of 79% and Adjusted EBITDA Margin of 40% Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Vericel Corporation (NASDAQ: VCEL - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven analysts that are covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price target among
Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VCEL.
U.S. House Trading
No House trades found for VCEL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.